Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 98, pseudogene (RNU6-98P) is classified as a pseudogene, specifically one of many U6 small nuclear RNA pseudogenes found in the human genome[2]. Pseudogenes are non-functional sequences similar to known genes; in this case, RNU6-98P is related to U6 small nuclear RNA, a crucial component of the spliceosome complex responsible for pre-mRNA splicing in the nucleus of eukaryotic cells[3][5]. Unlike the functional U6 snRNA gene, pseudogenes such as RNU6-98P are typically not expressed to produce functional RNA or protein, nor are they therapeutic drug targets or biological receptors. Their main scientific interest is evolutionary genomics and molecular annotation; they do not play a direct role in signaling, enzymatic function, or therapeutic intervention[2]. Additional context: - The main functional U6 snRNA is essential for catalyzing RNA splicing as part of the spliceosome, but pseudogenes like RNU6-98P are considered non-coding, non-functional genomic elements[3][5]. - RNU6-98P is not listed as involved in any disease mechanism or therapeutic intervention according to current major gene databases[2]. - Pseudogenes can occasionally gain novel regulatory functions (e.g., as non-coding RNAs with regulatory effects in other contexts), but no such function has been described for RNU6-98P. Assessment: - RNU6-98P is not a therapeutic target, does not encode a functional receptor or protein, and there are no known drugs or clinical implications directly linked to this entity. - The entry is included for genomic completeness but is not relevant for therapeutic targeting or biomarker development[2]. Summary: RNU6-98P is a non-functional pseudogene of the U6 small nuclear RNA family and is not a biological target for drugs, diagnostics, or therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 98, pseudogene (RNU6-98P).